{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:02:50Z","timestamp":1771545770295,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37545-4","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:36:07Z","timestamp":1770132967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insights into the structural differences between homo- and heterodimers enriched from a cocktail of monoclonal antibodies against SARS-CoV-2"],"prefix":"10.1038","volume":"16","author":[{"given":"Jennifer B.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuetian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepanshu","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary R.","family":"Oberholtzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna J.","family":"Skow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mushhood","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristinel","family":"Sandu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunhai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Rosconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica A.","family":"Pyles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"3","key":"37545_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/molecules29030585","volume":"29","author":"BG de la Torre","year":"2024","unstructured":"de la Torre, B. G. & Albericio, F. The pharmaceutical industry in 2023: an analysis of FDA drug approvals from the perspective of molecules. Molecules 29 (3), 585. https:\/\/doi.org\/10.3390\/molecules29030585 (2024).","journal-title":"Molecules"},{"issue":"5","key":"37545_CR2","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1080\/19420862.2016.1168960","volume":"8","author":"F Plath","year":"2016","unstructured":"Plath, F. et al. Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs. mAbs 8 (5), 928\u2013940. https:\/\/doi.org\/10.1080\/19420862.2016.1168960 (2016).","journal-title":"mAbs"},{"issue":"1","key":"37545_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jb\/mvt095","volume":"155","author":"T Iwura","year":"2013","unstructured":"Iwura, T., Fukuda, J., Yamazaki, K., Kanamaru, S. & Arisaka, F. Intermolecular interactions and conformation of antibody dimers present in IgG1 biopharmaceuticals. J. Biochem. 155 (1), 63\u201371. https:\/\/doi.org\/10.1093\/jb\/mvt095 (2013).","journal-title":"J. Biochem."},{"issue":"37","key":"37545_CR4","doi-asserted-by":"publisher","first-page":"13813","DOI":"10.1021\/acs.analchem.3c01602","volume":"95","author":"GY Liu","year":"2023","unstructured":"Liu, G. Y., Zhang, Z., Yan, Y., Wang, S. & Li, N. Discovery and characterization of an Acid-Labile Serine-Lysine Cross-Link in antibody High-Molecular-Weight species using a multipronged mass spectrometry approach. Anal. Chem. 95 (37), 13813\u201313821. https:\/\/doi.org\/10.1021\/acs.analchem.3c01602 (2023).","journal-title":"Anal. Chem."},{"issue":"1","key":"37545_CR5","doi-asserted-by":"publisher","first-page":"1781743","DOI":"10.1080\/19420862.2020.1781743","volume":"12","author":"G Rouby","year":"2020","unstructured":"Rouby, G., Tran, N. T., Leblanc, Y., Taverna, M. & Bihoreau, N. Investigation of monoclonal antibody dimers in a final formulated drug by separation techniques coupled to native mass spectrometry. mAbs 12 (1), 1781743. https:\/\/doi.org\/10.1080\/19420862.2020.1781743 (2020).","journal-title":"mAbs"},{"key":"37545_CR6","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1016\/j.csbj.2022.08.048","volume":"20","author":"Y Yin","year":"2022","unstructured":"Yin, Y. et al. Antibody interfaces revealed through structural mining. Comput. Struct. Biotechnol. J. 20, 4952\u20134968. https:\/\/doi.org\/10.1016\/j.csbj.2022.08.048 (2022).","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"37545_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.xphs.2019.04.021","volume":"109","author":"G Kijanka","year":"2020","unstructured":"Kijanka, G. et al. Monoclonal antibody dimers induced by low pH, Heat, or light exposure are not Immunogenic upon subcutaneous administration in a mouse model. J. Pharm. Sci. 109 (1), 730\u2013738. https:\/\/doi.org\/10.1016\/j.xphs.2019.04.021 (2020).","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"37545_CR8","doi-asserted-by":"publisher","first-page":"e0159328","DOI":"10.1371\/journal.pone.0159328","volume":"11","author":"MK Joubert","year":"2016","unstructured":"Joubert, M. K. et al. Use of in vitro assays to assess immunogenicity risk of Antibody-Based biotherapeutics. PLoS ONE. 11 (8), e0159328. https:\/\/doi.org\/10.1371\/journal.pone.0159328 (2016).","journal-title":"PLoS ONE"},{"issue":"1","key":"37545_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/curroncol31010007","volume":"31","author":"S Moufarrij","year":"2023","unstructured":"Moufarrij, S. & O\u2019Cearbhaill, R. E. Novel therapeutics in ovarian cancer: expanding the toolbox. Curr. Oncol. 31 (1), 97\u2013114. https:\/\/doi.org\/10.3390\/curroncol31010007 (2023).","journal-title":"Curr. Oncol."},{"issue":"1","key":"37545_CR10","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/s41467-024-46542-y","volume":"15","author":"D Hsiehchen","year":"2024","unstructured":"Hsiehchen, D. et al. The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial. Nat. Commun. 15 (1), 2178. https:\/\/doi.org\/10.1038\/s41467-024-46542-y (2024).","journal-title":"Nat. Commun."},{"issue":"1","key":"37545_CR11","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1038\/s41467-021-23832-3","volume":"12","author":"F Yang","year":"2021","unstructured":"Yang, F. et al. Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40. Nat. Commun. 12 (1), 3424. https:\/\/doi.org\/10.1038\/s41467-021-23832-3 (2021).","journal-title":"Nat. Commun."},{"key":"37545_CR12","doi-asserted-by":"publisher","unstructured":"Liu, D. & Shameem, M. Antiviral monoclonal antibody cocktails as a modern weapon in combating pandemics. Ther. Deliv. 0 (0). https:\/\/doi.org\/10.4155\/tde-2021-0079 (2021).","DOI":"10.4155\/tde-2021-0079"},{"issue":"6506","key":"37545_CR13","doi-asserted-by":"publisher","first-page":"eabd0831","DOI":"10.1126\/science.abd0831","volume":"369","author":"A Baum","year":"2020","unstructured":"Baum, A. et al. Antibody cocktail to SARS-CoV-2 Spike protein prevents rapid mutational escape seen with individual antibodies. Sci. (N York Ny). 369 (6506), eabd0831. https:\/\/doi.org\/10.1126\/science.abd0831 (2020).","journal-title":"Sci. (N York Ny)"},{"issue":"15","key":"37545_CR14","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1016\/j.cell.2021.06.002","volume":"184","author":"R Copin","year":"2021","unstructured":"Copin, R. et al. The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies. Cell 184 (15), 3949\u20133961e11. https:\/\/doi.org\/10.1016\/j.cell.2021.06.002 (2021).","journal-title":"Cell"},{"issue":"7","key":"37545_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","volume":"19","author":"WT Harvey","year":"2021","unstructured":"Harvey, W. T. et al. SARS-CoV-2 variants, Spike mutations and immune escape. Nat. Rev. Microbiol. 19 (7), 409\u2013424. https:\/\/doi.org\/10.1038\/s41579-021-00573-0 (2021).","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"37545_CR16","doi-asserted-by":"publisher","first-page":"2338301","DOI":"10.1080\/19420862.2024.2338301","volume":"16","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. Enrichment strategy and initial characterization of heterodimers enriched from a co-formulated cocktail of therapeutic antibodies against SARS-COV-2. mAbs 16 (1), 2338301. https:\/\/doi.org\/10.1080\/19420862.2024.2338301 (2024).","journal-title":"mAbs"},{"issue":"1","key":"37545_CR17","doi-asserted-by":"publisher","first-page":"1738691","DOI":"10.1080\/19420862.2020.1738691","volume":"12","author":"J Kim","year":"2020","unstructured":"Kim, J. et al. Analytical characterization of coformulated antibodies as combination therapy. mAbs 12 (1), 1738691. https:\/\/doi.org\/10.1080\/19420862.2020.1738691 (2020).","journal-title":"mAbs"},{"issue":"4","key":"37545_CR18","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1021\/acs.analchem.2c03099","volume":"95","author":"F Kuhne","year":"2023","unstructured":"Kuhne, F. et al. Identification of Hetero-aggregates in antibody Co-formulations by Multi-dimensional liquid chromatography coupled to mass spectrometry. Anal. Chem. 95 (4), 2203\u20132212. https:\/\/doi.org\/10.1021\/acs.analchem.2c03099 (2023).","journal-title":"Anal. Chem."},{"issue":"20","key":"37545_CR19","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1080\/10826076.2012.743724","volume":"35","author":"P Hong","year":"2012","unstructured":"Hong, P., Koza, S. & Bouvier, E. S. P. Size-Exclusion chromatography for the analysis of protein biotherapeutics and their aggregates. J. Liq Chromatogr. Relat. Technol. 35 (20), 2923\u20132950. https:\/\/doi.org\/10.1080\/10826076.2012.743724 (2012).","journal-title":"J. Liq Chromatogr. Relat. Technol."},{"key":"37545_CR20","doi-asserted-by":"publisher","unstructured":"Yang, X. et al. (eds) (Jin), Analysis and purification of IgG4 bispecific antibodies by a mixed-mode chromatography. Anal Biochem. 484173\u2013179. (2015). https:\/\/doi.org\/10.1016\/j.ab.2015.06.014","DOI":"10.1016\/j.ab.2015.06.014"},{"issue":"1","key":"37545_CR21","doi-asserted-by":"publisher","first-page":"2362788","DOI":"10.1080\/19420862.2024.2362788","volume":"16","author":"E Park","year":"2024","unstructured":"Park, E. & Izadi, S. Molecular surface descriptors to predict antibody developability: sensitivity to parameters, structure models, and conformational sampling. mAbs 16 (1), 2362788. https:\/\/doi.org\/10.1080\/19420862.2024.2362788 (2024).","journal-title":"mAbs"},{"key":"37545_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fimmu.2016.00388","volume":"7","author":"CL Townsend","year":"2016","unstructured":"Townsend, C. L. et al. Significant differences in physicochemical properties of human Immunoglobulin kappa and lambda CDR3 regions. Front. Immunol. 7, 388. https:\/\/doi.org\/10.3389\/fimmu.2016.00388 (2016).","journal-title":"Front. Immunol."},{"issue":"1","key":"37545_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s42003-023-05744-8","volume":"7","author":"MIJ Raybould","year":"2024","unstructured":"Raybould, M. I. J., Turnbull, O. M., Suter, A., Guloglu, B. & Deane, C. M. Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling. Commun. Biol. 7 (1), 62. https:\/\/doi.org\/10.1038\/s42003-023-05744-8 (2024).","journal-title":"Commun. Biol."},{"issue":"1","key":"37545_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jb\/mvt095","volume":"155","author":"T Iwura","year":"2014","unstructured":"Iwura, T., Fukuda, J., Yamazaki, K., Kanamaru, S. & Arisaka, F. Intermolecular interactions and conformation of antibody dimers present in IgG1 biopharmaceuticals. J. Biochem. 155 (1), 63\u201371. https:\/\/doi.org\/10.1093\/jb\/mvt095 (2014).","journal-title":"J. Biochem."},{"issue":"6","key":"37545_CR25","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1080\/19420862.2017.1331803","volume":"9","author":"Y Luo","year":"2017","unstructured":"Luo, Y. et al. Evidence for intermolecular domain exchange in the fab domains of dimer and oligomers of an IgG1 monoclonal antibody. mAbs 9 (6), 916\u2013926. https:\/\/doi.org\/10.1080\/19420862.2017.1331803 (2017).","journal-title":"mAbs"},{"issue":"1","key":"37545_CR26","doi-asserted-by":"publisher","first-page":"2127172","DOI":"10.1080\/19420862.2022.2127172","volume":"14","author":"MJ Knight","year":"2022","unstructured":"Knight, M. J., Floret, L., Patel, N., O\u2019Hara, J. & Rodriguez, E. The impact of forced degradation conditions on mAb dimer formation and subsequent influence on aggregation propensity. mAbs 14 (1), 2127172. https:\/\/doi.org\/10.1080\/19420862.2022.2127172 (2022).","journal-title":"mAbs"},{"issue":"12","key":"37545_CR27","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1021\/jasms.1c00289","volume":"32","author":"Y Yan","year":"2021","unstructured":"Yan, Y. et al. Post-Column Denaturation-Assisted native Size-Exclusion Chromatography\u2013Mass spectrometry for rapid and In-Depth characterization of high molecular weight variants in therapeutic monoclonal antibodies. J. Am. Soc. Mass. Spectrom. 32 (12), 2885\u20132894. https:\/\/doi.org\/10.1021\/jasms.1c00289 (2021).","journal-title":"J. Am. Soc. Mass. Spectrom."},{"issue":"10","key":"37545_CR28","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.1021\/ac500334k","volume":"86","author":"M Liu","year":"2014","unstructured":"Liu, M., Zhang, Z., Cheetham, J., Ren, D. & Zhou, Z. S. Discovery and characterization of a Photo-Oxidative Histidine-Histidine Cross-Link in IgG1 antibody utilizing 18O\u2013Labeling and mass spectrometry. Anal. Chem. 86 (10), 4940\u20134948. https:\/\/doi.org\/10.1021\/ac500334k (2014).","journal-title":"Anal. Chem."},{"issue":"1\u20132","key":"37545_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0301-4622(94)00143-8","volume":"55","author":"SE Harding","year":"1995","unstructured":"Harding, S. E. On the hydrodynamic analysis of macromolecular conformation. Biophys. Chem. 55 (1\u20132), 69\u201393. https:\/\/doi.org\/10.1016\/0301-4622(94)00143-8 (1995).","journal-title":"Biophys. Chem."},{"issue":"4\u20135","key":"37545_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00249-023-01629-0","volume":"52","author":"JS Philo","year":"2023","unstructured":"Philo, J. S. SEDNTERP: a calculation and database utility to aid interpretation of analytical ultracentrifugation and light scattering data. Eur. Biophys. J. 52 (4\u20135), 233\u2013266. https:\/\/doi.org\/10.1007\/s00249-023-01629-0 (2023).","journal-title":"Eur. Biophys. J."},{"issue":"6506","key":"37545_CR31","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.abd0827","volume":"369","author":"J Hansen","year":"2020","unstructured":"Hansen, J. et al. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Sci. (N York Ny). 369 (6506), 1010\u20131014. https:\/\/doi.org\/10.1126\/science.abd0827 (2020).","journal-title":"Sci. (N York Ny)"},{"issue":"1","key":"37545_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molimm.2013.11.011","volume":"58","author":"J Yang","year":"2014","unstructured":"Yang, J., Goetze, A. M. & Flynn, G. C. Assessment of naturally occurring covalent and total dimer levels in human IgG1 and IgG2. Mol. Immunol. 58 (1), 108\u2013115. https:\/\/doi.org\/10.1016\/j.molimm.2013.11.011 (2014).","journal-title":"Mol. Immunol."},{"issue":"4","key":"37545_CR33","doi-asserted-by":"publisher","first-page":"e0195729","DOI":"10.1371\/journal.pone.0195729","volume":"13","author":"I Kustiawan","year":"2018","unstructured":"Kustiawan, I. et al. Dimeric IgG complexes from IVIg are incapable of inducing in vitro neutrophil degranulation or complement activation. PLoS ONE. 13 (4), e0195729. https:\/\/doi.org\/10.1371\/journal.pone.0195729 (2018).","journal-title":"PLoS ONE"},{"issue":"7838","key":"37545_CR34","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","volume":"588","author":"Z Ke","year":"2020","unstructured":"Ke, Z. et al. Structures and distributions of SARS-CoV-2 Spike proteins on intact virions. Nature 588 (7838), 498\u2013502. https:\/\/doi.org\/10.1038\/s41586-020-2665-2 (2020).","journal-title":"Nature"},{"issue":"12","key":"37545_CR35","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1002\/jps.23754","volume":"102","author":"RE Iacob","year":"2013","unstructured":"Iacob, R. E. et al. Investigating monoclonal antibody aggregation using a combination of H\/DX\u2010MS and other biophysical measurements. J. Pharm. Sci. 102 (12), 4315\u20134329. https:\/\/doi.org\/10.1002\/jps.23754 (2013).","journal-title":"J. Pharm. Sci."},{"issue":"577","key":"37545_CR36","doi-asserted-by":"publisher","first-page":"eabf1555","DOI":"10.1126\/scitranslmed.abf1555","volume":"13","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci. Transl Med. 13 (577), eabf1555. https:\/\/doi.org\/10.1126\/scitranslmed.abf1555 (2021).","journal-title":"Sci. Transl Med."},{"issue":"44","key":"37545_CR37","doi-asserted-by":"publisher","first-page":"e2107148118","DOI":"10.1073\/pnas.2107148118","volume":"118","author":"L Sun","year":"2021","unstructured":"Sun, L. et al. Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG. Proc. Natl. Acad. Sci. United States Am. 118 (44), e2107148118. https:\/\/doi.org\/10.1073\/pnas.2107148118 (2021).","journal-title":"Proc. Natl. Acad. Sci. United States Am."},{"issue":"3","key":"37545_CR38","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.4049\/jimmunol.160.3.1219","volume":"160","author":"KB Renegar","year":"1998","unstructured":"Renegar, K. B., Jackson, G. D. & Mestecky, J. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J. Immunol. (Baltim Md: 1950). 160 (3), 1219\u20131223 (1998).","journal-title":"J. Immunol. (Baltim Md: 1950)"},{"issue":"1","key":"37545_CR39","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1038\/s41467-019-12367-3","volume":"10","author":"R Twarock","year":"2019","unstructured":"Twarock, R. & Luque, A. Structural puzzles in virology solved with an overarching icosahedral design principle. Nat. Commun. 10 (1), 4414. https:\/\/doi.org\/10.1038\/s41467-019-12367-3 (2019).","journal-title":"Nat. Commun."},{"issue":"7","key":"37545_CR40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH image to imageJ: 25 years of image analysis. Nat. Methods. 9 (7), 671\u2013675. https:\/\/doi.org\/10.1038\/nmeth.2089 (2012).","journal-title":"Nat. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37545-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37545-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37545-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:06:09Z","timestamp":1771542369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37545-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37545"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37545-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was sponsored by Regeneron Pharmaceuticals, Inc. The authors declare the following competing financial interest(s): J.B.N, S.L., Y.Y., D.C., Z.R.O., Y.Z., D.J.S., M.S., C.S., S.W., N.L., M.C.F., M.P.R., and E.A.P. are full-time employees and shareholders of Regeneron Pharmaceuticals, Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7024"}}